Insider Transactions in Q2 2023 at Trevi Therapeutics, Inc. (TRVI)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2023
|
Farrell Simon Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+12.04%
|
$0
$0.51 P/Share
|
|
Jun 12
2023
|
Lisa Delfini Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
610
-2.02%
|
$1,220
$2.64 P/Share
|
|
Jun 12
2023
|
Lisa Delfini Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,291
+7.05%
|
$0
$0.51 P/Share
|
|
May 11
2023
|
Lisa Delfini Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
562
-1.97%
|
$1,124
$2.89 P/Share
|
|
May 11
2023
|
Lisa Delfini Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,291
+7.45%
|
$0
$0.51 P/Share
|
|
Apr 11
2023
|
Lisa Delfini Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
840
-3.11%
|
$840
$1.84 P/Share
|
|
Apr 11
2023
|
Lisa Delfini Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,292
+7.82%
|
$0
$0.51 P/Share
|